Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jan;99(4):e18887.
doi: 10.1097/MD.0000000000018887.

A novel de novo MYH9 mutation in MYH9-related disease: A case report and review of literature

Affiliations

A novel de novo MYH9 mutation in MYH9-related disease: A case report and review of literature

Qi Ai et al. Medicine (Baltimore). 2020 Jan.

Abstract

Introduction: MYH9-related disease (MYH9-RD) is a rare autosomal dominant disorder caused by mutations in MYH9, which is responsible for encoding nonmuscle myosin heavy chains IIA (NMMHCIIA). MYH9-RD is clinically characterized by congenital macrothrombocytopenia, granulocyte inclusions variably associated with the risk of developing progressive sensorineural deafness, cataracts and nephropathy.

Patient concerns: A 5-year-old boy had a history of a mild bleeding tendency and chronic thrombocytopenia, first identified at four months of age. No other family members were noted to have similar clinical features or hematologic disorders.

Diagnoses: The boy was diagnosed with MYH9-RD. Light microscopic examination of peripheral blood films (Wright-Giemsa stain) showed marked platelet macrocytosis with giant platelets and basophilic Döhle-like inclusions in 83% of the neutrophils. Immunofluorescence analysis disclosed a type II pattern, manifested by neutrophils which contained several circle-to-oval shaped cytoplasmic NMMMHCA-positive granules. Sequencing analysis of MYH9-RD genes was carried out and revealed a novel missense mutation of c.97T>G (p.W33G) in the patient but not in his parents.

Intervention: No treatment is necessary. Recognition of MYH9-RD is important to Avoiding unnecessary and potentially harmful treatments.

Outcomes: The patient's condition remained stable during the follow-up.

Conclusions: As a result of identifying this missense mutation in this particular case, we have added c.97T>G (p.W33G) to the broad spectrum of potential MYH9 mutations.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

Figure 1
Figure 1
Platelet and neutrophil morphology (original magnification ×1000). (A) Light micrograph of Wright–Giemsa-stained peripheral blood. Typical large inclusion body in a neutrophil is indicated by an arrowhead. (B) Light micrograph of Wright–Giemsa-stained peripheral blood. A giant platelet as large as erythrocyte and a cytoplasmic inclusion body in a neutrophil were observed. (C) Immunofluorescence localization of myosin-9 in neutrophil granulocyte. Normal myosin-9 distribution pattern is shown for comparison. (D) An immunofluorescence micrograph of a neutrophil immunostained with anti-NMMHCIIA localization.
Figure 2
Figure 2
The results of direct sequencing of MYH9 exon 2 in the proband and family numbers. The proband was heterozygous for a missense mutation of c.97T>G (p.W33G). His parents did not have the mutation, indicating a de novo occurrence of the mutation in the proband.

Similar articles

References

    1. Hannoun C, Dab W, Cohen JM. A new influenza surveillance system in France: the Ile-de-France “GROG”. 1. Principles and methodology. Eur J Epidemiol 1989;5:285–93. - PubMed
    1. Favier R, Feriel J, Favier M, et al. First successful use of eltrombopag before surgery in a child with MYH9-related thrombocytopenia. Pediatrics 2013;132:e793–5. - PubMed
    1. Althaus K, Greinacher A. MYH9-related platelet disorders. Semin Thromb Hemost 2009;35:189–203. - PubMed
    1. Eckly A, Strassel C, Freund M, et al. Abnormal megakaryocyte morphology and proplatelet formation in mice with megakaryocyte-restricted MYH9 inactivation. Blood 2009;113:3182–9. - PubMed
    1. Seri M, Pecci A, Di Bari F, et al. MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness. Medicine (Baltimore) 2003;82:203–15. - PubMed

Supplementary concepts